Now showing items 1-1 of 1
Evaluating optimal therapy robustness by virtual expansion of a sample population, with a case study in cancer immunotherapy
(National Academy of Sciences, 2017)
Cancer is a highly heterogeneous disease, exhibiting spatial and temporal variations that pose challenges for designing robust therapies. Here, we propose the VEPART (Virtual Expansion of Populations for Analyzing Robustness ...